Literature DB >> 16783830

Permanent unilateral hearing loss after radiotherapy for parotid gland tumors.

Lisa van der Putten1, Remco de Bree, John T Plukker, Johannes A Langendijk, Cas Smits, Fred R Burlage, C René Leemans.   

Abstract

BACKGROUND: The purpose of this retrospective study was to determine the long-term effects of radiotherapy on hearing function in patients who underwent parotidectomy and postoperative radiotherapy for unilateral tumors of the parotid gland.
METHODS: An extensive set of tests was used to measure hearing loss. The mean dose on middle ear, cochlea, and Eustachian tube was estimated with a CT-planning system.
RESULTS: A hearing loss of > or = 15 dB in 3 frequencies was found in 32% of the 52 patients included in the study. Patients with an asymmetrical hearing loss received a higher mean dose on the hearing structures (p < .002). The threshold dose for clinically relevant hearing loss was found at 50 Gy on the cochlea and Eustachian tube.
CONCLUSIONS: Radiation-induced hearing loss is a common complication. A mean dose of > 50 Gy on the cochlea should be avoided. (c) 2006 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2006        PMID: 16783830     DOI: 10.1002/hed.20426

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  11 in total

Review 1.  Radiation therapy and hearing loss.

Authors:  Niranjan Bhandare; Andrew Jackson; Avraham Eisbruch; Charlie C Pan; John C Flickinger; Patrick Antonelli; William M Mendenhall
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

Review 2.  Treatment of late sequelae after radiotherapy for head and neck cancer.

Authors:  Primož Strojan; Katherine A Hutcheson; Avraham Eisbruch; Jonathan J Beitler; Johannes A Langendijk; Anne W M Lee; June Corry; William M Mendenhall; Robert Smee; Alessandra Rinaldo; Alfio Ferlito
Journal:  Cancer Treat Rev       Date:  2017-07-18       Impact factor: 12.111

3.  Prospective study on the dose distribution to the acoustic structures during postoperative 3D conformal radiotherapy for parotid tumors: dosimetric and audiometric aspects.

Authors:  Barbara A Jereczek-Fossa; Elena Rondi; Andrzej Zarowski; Alberto D'Onofrio; Daniela Alterio; Mario Ciocca; Livia Corinna Bianchi; Marco Krengli; Luca Calabrese; Mohssen Ansarin; Gioacchino Giugliano; Roberto Orecchia
Journal:  Strahlenther Onkol       Date:  2011-05-16       Impact factor: 3.621

4.  Measuring uncertainty in dose delivered to the cochlea due to setup error during external beam treatment of patients with cancer of the head and neck.

Authors:  M Yan; D Lovelock; M Hunt; J Mechalakos; Y Hu; H Pham; A Jackson
Journal:  Med Phys       Date:  2013-12       Impact factor: 4.071

Review 5.  Follow-up strategies in head and neck cancer other than upper aerodigestive tract squamous cell carcinoma.

Authors:  Antoine Digonnet; Marc Hamoir; Guy Andry; Vincent Vander Poorten; Missak Haigentz; Johannes A Langendijk; Remco de Bree; Michael L Hinni; William M Mendenhall; Vinidh Paleri; Alessandra Rinaldo; Jochen A Werner; Robert P Takes; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-10-26       Impact factor: 2.503

6.  Radiotherapy for vestibular schwannoma: Review of recent literature results.

Authors:  Giuseppina Apicella; Marina Paolini; Letizia Deantonio; Laura Masini; Marco Krengli
Journal:  Rep Pract Oncol Radiother       Date:  2016-02-28

7.  Impact of radiation technique, radiation fraction dose, and total cisplatin dose on hearing : Retrospective analysis of 29 medulloblastoma patients.

Authors:  Sergiu Scobioala; Ross Parfitt; Peter Matulat; Christopher Kittel; Fatemeh Ebrahimi; Heidi Wolters; Antoinette Am Zehnhoff-Dinnesen; Hans Theodor Eich
Journal:  Strahlenther Onkol       Date:  2017-09-08       Impact factor: 3.621

8.  Normal tissue complication probability modeling for cochlea constraints to avoid causing tinnitus after head-and-neck intensity-modulated radiation therapy.

Authors:  Tsair-Fwu Lee; Shyh-An Yeh; Pei-Ju Chao; Liyun Chang; Chien-Liang Chiu; Hui-Min Ting; Hung-Yu Wang; Yu-Jie Huang
Journal:  Radiat Oncol       Date:  2015-09-17       Impact factor: 3.481

9.  Cochlea sparing optimized radiotherapy for nasopharyngeal carcinoma.

Authors:  Enkelejda Lamaj; Erwin Vu; Janita E van Timmeren; Chiara Leonardi; Louise Marc; Izabela Pytko; Matthias Guckenberger; Panagiotis Balermpas
Journal:  Radiat Oncol       Date:  2021-04-01       Impact factor: 3.481

10.  Cochlea-sparing acoustic neuroma treatment with 4π radiation therapy.

Authors:  Kaley Woods; Percy Lee; Tania Kaprealian; Isaac Yang; Ke Sheng
Journal:  Adv Radiat Oncol       Date:  2018-02-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.